J. Honnorat

P. Adeleine, J. Honnorat, P. Trouillas, 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

TCF12 is mutated in anaplastic oligodendroglioma

F. Ducray, M. Sanson, R. Houlston, 2015, Nature Communications.

Avoiding New Biopsies by Identification of IDH1 and TERT Promoter Mutation in Nondiagnostic Biopsies From Glioma Patients.

F. Ducray, M. Gabut, J. Honnorat, 2020, Neurosurgery.

IQGAP1 protein specifies amplifying cancer cells in glioblastoma multiforme.

F. Ducray, J. Honnorat, A. Jouvet, 2006, Cancer research.

Extensive Expression of Collapsin Response Mediator Protein 5 (CRMP5) is a Specific Marker of High-grade Lung Neuroendocrine Carcinoma

J. Honnorat, F. Thivolet, L. Chalabreysse, 2008, The American journal of surgical pathology.

Cell- and Single Molecule-Based Methods to Detect Anti-N-Methyl-D-Aspartate Receptor Autoantibodies in Patients With First-Episode Psychosis From the OPTiMiSE Project

M. Leboyer, H. Gréa, J. Honnorat, 2017, Biological Psychiatry.

Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, France.

F. Ducray, J. Honnorat, D. Frappaz, 2014, Revue neurologique.

[18F]Fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti‐Hu antibodies

A. Vighetto, C. Tilikete, D. Michel, 2000, Annals of neurology.

The Evolving Genomic Landscape of Recurrent Gliomas

L. Chin, Leena E Williams, F. Lieberman, 2015 .

Abnormal expression of truncated CRMP-1 protein in the brain cortex of MPSIIIB mice.

J. Honnorat, D. Cheillan, M. Belin, 2008, Molecular genetics and metabolism.

Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina

D. Michel, J. Honnorat, J. Antoine, 1993, Journal of the Neurological Sciences.

Collapsin Response Mediator Protein 5 (CRMP5) Induces Mitophagy, Thereby Regulating Mitochondrion Numbers in Dendrites

J. Honnorat, N. Chounlamountri, C. Auger, 2013, The Journal of Biological Chemistry.

Cytoskeleton and CRMPs in Neuronal Morphogenesis and Neurological Diseases: Potential Targets for New Therapies

J. Honnorat, R. Khanna, A. Duchemin, 2016 .

Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases

M. Taussig, J. Honnorat, J. Antoine, 2021, Neurology: Neuroimmunology & Neuroinflammation.

[Supervision of low-grade gliomas with multiparametric MR imaging: research of radiologic indicators of malignancy transformation].

J. Honnorat, D. Frappaz, F. Cotton, 2008, Neuro-Chirurgie.

Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies

E. Mignot, J. Honnorat, A. Ambati, 2020, Journal of Neurology.

NG2-expressing glial precursor cells are a new potential oligodendroglioma cell initiating population in N-ethyl-N-nitrosourea-induced gliomagenesis.

E. Barbier, J. Honnorat, J. Baudier, 2010, Carcinogenesis.

New targeted therapies in pituitary carcinoma resistant to temozolomide

F. Ducray, J. Honnorat, F. Borson‐Chazot, 2012, Pituitary.

Psychiatric symptoms in anti glutamic acid decarboxylase associated limbic encephalitis in adults: a systematic review

G. Huberfeld, J. Honnorat, C. Azuar, 2020, Neuroscience & Biobehavioral Reviews.

Guidelines on the management of infectious encephalitis in adults.

J. Honnorat, P. Azouvi, N. Girard, 2017, Medecine et maladies infectieuses.

Infectious encephalitis: Management without etiological diagnosis 48 hours after onset

J. Honnorat, P. Fillâtre, Y. Crabol, 2017, Médecine et Maladies Infectieuses.

Immune-mediated ataxias.

J. Honnorat, K. Rostásy, B. Joubert, 2018, Handbook of clinical neurology.

G303V tau mutation presenting with progressive supranuclear palsy–like features

J. Honnorat, E. Broussolle, S. Thobois, 2012, Movement disorders : official journal of the Movement Disorder Society.

Guidelines for treatment of immune-mediated cerebellar ataxias

H. Mitoma, J. Honnorat, M. Hadjivassiliou, 2015, Cerebellum & Ataxias.

Association of antineural autoantibodies in a patient with paraneoplastic cerebellar syndrome and small cell lung carcinoma.

J. Honnorat, J. Dalmau, J. Antoine, 1997, Journal of neurology, neurosurgery, and psychiatry.

Spectrum of paraneoplastic disease associated with lymphoma

J. Honnorat, B. Giometto, C. Briani, 2011, Neurology.

Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor.

V. de la Sayette, J. Honnorat, G. Defer, 1998, Archives of neurology.

Role of LGI1 protein in synaptic transmission: From physiology to pathology

J. Honnorat, O. Pascual, A. Vogrig, 2021, Neurobiology of Disease.

Cerebrospinal Fluid IL-17A Could Predict Acute Disease Severity in Non-NMDA-Receptor Autoimmune Encephalitis

J. Honnorat, C. Lebrun-Frénay, V. Bourg, 2021, Frontiers in Immunology.

Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.

M. Baulac, V. Navarro, J. Honnorat, 2016, Brain : a journal of neurology.

Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.

F. Ducray, J. Honnorat, J. Delattre, 2016, JAMA neurology.

Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis.

S. Rheims, J. Honnorat, J. Antoine, 2017, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Nonparaneoplastic autoimmune cerebellar ataxias

J. Honnorat, B. Joubert, 2019, Current opinion in neurology.

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis

F. Ducray, P. Convers, J. Honnorat, 2017, Neurology: Neuroimmunology & Neuroinflammation.

A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy.

J. Hoenicka, J. Honnorat, S. Thobois, 2005, Archives of neurology.

Ephrin-B 3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA 4

Berger, J. Honnorat, I. Treilleux, 2017 .

Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4

J. Honnorat, I. Treilleux, P. Mehlen, 2017, Oncotarget.

Combined analysis of MGMT methylation and dynamic-susceptibility-contrast MRI for the distinction between early and pseudo-progression in glioblastoma patients.

F. Ducray, S. Gouttard, J. Honnorat, 2019, Revue neurologique.

Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity

J-Y Delattre, Y. Marie, J. Honnorat, 2014, Oncogene.

Effects of diabetes type and treatment on zinc status in diabetes mellitus

J. Honnorat, J. Orgiazzi, C. Broussolle, 2007, Biological Trace Element Research.

Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies

J. Honnorat, B. Giometto, J. Delattre, 1995, Neurology.

Ketamine/xylazine and barbiturates modulate microglial morphology and motility differently in a mouse model

J. Honnorat, O. Pascual, F. Verdonk, 2020, PloS one.

Pseudotumoral presentation of cerebral amyloid angiopathy–related inflammation

F. Ducray, J. Honnorat, N. Nighoghossian, 2016, Neurology.

Impact of anti-CASPR2 autoantibodies from patients with autoimmune encephalitis on CASPR2/TAG-1 interaction and Kv1 expression.

J. Honnorat, O. Pascual, N. Noraz, 2019, Journal of autoimmunity.

Paraneoplastic disorders of the central and peripheral nervous systems.

J. Honnorat, A. Didelot, 2014, Handbook of clinical neurology.

Autoimmune limbic encephalitis

J. Honnorat, A. Didelot, 2011 .

Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.

J. Honnorat, B. Giometto, G. Bertolini, 2010, Archives of neurology.

[Limbic encephalitis. A misdiagnosed syndrome].

F. Ducray, J. Honnorat, S. Cartalat‐Carel, 2008, Psychologie & neuropsychiatrie du vieillissement.

[Breast cancer in the early stage].

R. J. Jones, M. Espié, G. Giaccone, 2012, Gan no rinsho. Japan journal of cancer clinics.

Central nervous system complications associated with immune checkpoint inhibitors

F. Ducray, C. Marchal, J. Honnorat, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors

J. Honnorat, V. Desestret, A. Vogrig, 2020, Therapeutic advances in neurological disorders.

Abdominal Segmental Myoclonus Mimicking Belly Dancer Dyskinesias in CASPR2 Antibody Encephalomyelitis

J. Honnorat, G. Castelnovo, D. Renard, 2021, Movement disorders clinical practice.

Structural mapping of hot spots within human CASPR2 discoidin domain for autoantibody recognition.

J. Honnorat, N. Noraz, Heli Liu, 2019, Journal of autoimmunity.

Movement disorders in autoimmune encephalitis and paraneoplastic neurological syndromes.

J. Honnorat, B. Joubert, J. Honnorat, 2018, Revue neurologique.

Update on paraneoplastic neurological syndromes

J. Honnorat, A. Didelot, 2009, Current opinion in oncology.

Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy

F. Ducray, J. Honnorat, B. Joubert, 2018, Journal of Neuro-Oncology.

Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies

P. Convers, D. Michel, J. Honnorat, 1999, Journal of neurology, neurosurgery, and psychiatry.

Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration

J. Honnorat, I. Treilleux, I. Ray-Coquard, 2018, Acta Neuropathologica.

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

B. Chauffert, J. Honnorat, D. Frappaz, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical Presentation and Mechanisms of Immune-Mediated Cerebellar Ataxia

J. Honnorat, 2002 .

Limbic encephalitis and immunological perturbations in two patients with thymoma.

D. Michel, J. Honnorat, J. Antoine, 1995, Journal of neurology, neurosurgery, and psychiatry.

Paraneoplastic encephalitis: clinically based approach on diagnosis and management

J. Honnorat, A. Vogrig, S. Muñiz-Castrillo, 2022, Postgraduate medical journal.

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

J. Honnorat, O. Lambotte, F. Bourdain, 2019, Journal of Immunotherapy for Cancer.

Epidemiology of paraneoplastic neurological syndromes: a population-based study

G. Gigli, J. Honnorat, Francesco Brigo, 2019, Journal of Neurology.

Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome

F. Ducray, J. Honnorat, F. Cotton, 2018, Journal of Neurology.

Early‐onset immunotherapy by intravenous immunoglobulin and corticosteroids in well characterized onconeural‐antibody‐positive paraneoplastic neurological syndrome

J. Honnorat, 2014, Clinical and experimental immunology.

Therapeutic approaches in antibody-associated central nervous system pathologies.

J. Honnorat, 2014, Revue neurologique.

Paraneoplastic Neurological Syndromes: General Treatment Overview

J. Honnorat, A. Viaccoz, 2013, Current Treatment Options in Neurology.

Paraneoplastic Neurological Syndromes: General Treatment

J. Honnorat, Overviewlien Viaccoz, 2013 .

New concepts in paraneoplastic neurological syndromes.

J. Honnorat, A. Viaccoz, 2011, Revue neurologique.

[Paraneoplastic neurological syndromes].

J. Honnorat, S. Muñiz-Castrillo, A. Didelot, 2011, La Revue de medecine interne.

Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum

J. Honnorat, S. E. Monstad, C. Vedeler, 2004, Journal of Neuroimmunology.

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone

J. Honnorat, J. Delattre, P. Broët, 2000, Journal of neurology, neurosurgery, and psychiatry.

Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

W. Mason, M. Rosenblum, F. Valldeoriola, 1997, Brain : a journal of neurology.

Extensive myelitis associated with anti-NMDA receptor antibodies

P. Vermersch, J. Honnorat, G. Baille, 2013, BMC Neurology.

Neurologic Adverse Events of Immune Checkpoint Inhibitors

G. Gigli, J. Honnorat, A. Vogrig, 2021, Neurology.

Management of glioblastoma: comparison of clinical practices and cost‐effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital

F. Ducray, J. Honnorat, D. Frappaz, 2014, Journal of clinical pharmacy and therapeutics.

Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors

F. Ducray, C. Tilikete, J. Honnorat, 2020, Neurology.

Clinical presentation of immune-mediated cerebellar ataxia.

J. Honnorat, G. Demarquay, 2011, Revue neurologique.

CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.

F. Ducray, J. Honnorat, E. Jouanneau, 2015, Neuro-oncology.

Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma

J. Honnorat, D. Poncet, R. Bolbos, 2015, Molecular Cancer.

Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis

J. Honnorat, C. Birzu, D. Psimaras, 2022, Brain communications.

Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis.

E. Mignot, J. Honnorat, V. Wucher, 2021, Brain : a journal of neurology.

Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.

F. Ducray, J. Honnorat, A. Idbaih, 2015, JAMA neurology.

Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome

R. Balice-Gordon, J. Honnorat, C. Bien, 2011, Neurology.

Brain immunohistopathological study in a patient with anti‐NMDAR encephalitis

P. Convers, J. Honnorat, J. Antoine, 2011, European journal of neurology.

Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter

Jennie W. Taylor, I. Mellinghoff, J. Honnorat, 2022, Neuro-oncology.

Acute‐onset chorea, dystonia, and cardiac fibroelastoma in a child: A paraneoplastic association?

J. Honnorat, B. Echenne, M. Milh, 2013, Movement disorders : official journal of the Movement Disorder Society.

Giant lambl excrescences. An unusual source of cerebral embolism.

J. Honnorat, G. Chazot, P. Trouillas, 1997, Archives of neurology.

Dysregulation of the hippocampal neuronal network by LGI1 auto-antibodies

J. Honnorat, O. Pascual, Céline Malleval, 2022, PloS one.

[Alexander's disease in adults and diffuse cerebral gliomatosis in 2 members of the same family].

J. Honnorat, N. Kopp, C. Ribot, 1993, Revue neurologique.

Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.

Caroline Dehais, François Ducray, Catherine Carpentier, 2014, Neuro-oncology.

Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas

Olivier Langlois, Damien Ricard, Jean-Yves Delattre, 2016, Nature Communications.

Histiocytic sarcoma of the central nervous system: a challenging diagnosis.

F. Berger, J. Honnorat, E. Broussolle, 2012, QJM : monthly journal of the Association of Physicians.

Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies

J. Honnorat, C. Dehais, J. Delattre, 2017, Neurology: Neuroimmunology & Neuroinflammation.

Autoimmune neuromyotonia

J. Honnorat, B. Joubert, A. Pegat, 2022, Current opinion in neurology.

Characteristics in limbic encephalitis with anti–adenylate kinase 5 autoantibodies

F. Ducray, J. Honnorat, F. Tison, 2017, Neurology.

Course of valvular strands in patients with stroke: cooperative study with transesophageal echocardiography.

A. Vighetto, P. Ryvlin, P. Adeleine, 1998, American heart journal.

[Neurological complications of cancer].

J. Honnorat, S. Cartalat‐Carel, 2003, La Revue du praticien.

The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?

D. Pham‐Dinh, J. Honnorat, M. Ghandour, 2012, International Journal of Developmental Neuroscience.

Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine

J. Honnorat, C. Broussolle, P. Sève, 2016, Clinical Drug Investigation.

Intracranial non-myxoid angiomatoid fibrous histiocytoma with EWSR1-CREB1 transcript fusion treated with doxorubicin: A case report

F. Ducray, J. Honnorat, D. Pissaloux, 2021, Molecular and clinical oncology.

Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice.

J. Honnorat, N. Nighoghossian, S. Nataf, 2009, Stroke.

USPIO-Enhanced MRI of Neuroinflammation at the Sub-Acute Stage of Ischemic Stroke: Preliminary Data

J. Honnorat, N. Nighoghossian, J. Froment, 2007, Cerebrovascular Diseases.

Paraneoplastic anti‐CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy

M. Magistris, J. Honnorat, J. Antoine, 2001, Annals of neurology.

Paraneoplastic demyelinating neuropathy, subacute sensory neuropathy, and anti‐hu antibodies: Clinicopathological study of an autopsy case

P. Convers, D. Michel, J. Honnorat, 1998, Muscle & nerve.

Cerebrospinal Fluid Dendritic Cells Infiltrate the Brain Parenchyma and Target the Cervical Lymph Nodes under Neuroinflammatory Conditions

J. Honnorat, S. Nataf, M. Belin, 2008, PloS one.

How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update

J. Honnorat, A. Vogrig, B. Joubert, 2021, Journal of Neurology.

Associations between HLA and autoimmune neurological diseases with autoantibodies

J. Honnorat, A. Vogrig, S. Muñiz-Castrillo, 2020, Autoimmunity Highlights.

Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndrome

J. Honnorat, J. Delattre, F. Authier, 2002, Journal of Neuroimmunology.

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors

F. Ducray, J. Honnorat, V. Desestret, 2019, Neurology: Neuroimmunology & Neuroinflammation.

Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature

G. Gigli, J. Honnorat, M. Fabris, 2019, The Cerebellum.

Up-front temozolomide in elderly patients with glioblastoma

M. Sanson, J. Honnorat, O. Chinot, 2010, Journal of Neuro-Oncology.

Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration

J. Honnorat, P. S. Sillevis Smitt, R. Voltz, 2015, Neurology: Neuroimmunology & Neuroinflammation.

HLA-DQ2+ individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes

J. Honnorat, J. Gratama, P. Smitt, 2010, Journal of Neuroimmunology.

CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis

F. Ducray, J. Honnorat, O. Pascual, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis.

F. Ducray, J. Honnorat, A. Mailles, 2014, The Journal of infection.

PET follow-up in a case of anti-NMDAR encephalitis: arguments for cingulate limbic encephalitis

J. Honnorat, I. Namer, M. Diaconu, 2012, Epileptic disorders : international epilepsy journal with videotape.

Stroke MRI May Result in a Therapeutic Dilemma

J. Honnorat, N. Nighoghossian, M. Hermier, 2006, European Neurology.

Cerebellar Ataxia With Anti-DNER Antibodies

E. Mignot, J. Honnorat, M. Manto, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Cerebellar Ataxia With Anti-DNER Antibodies Outcomes and Immunologic Features

E. Mignot, J. Honnorat, M. Manto, 2022 .

POP66, A Paraneoplastic Encephalomyelitis-related Antigen, Is a Marker of Adult Oligodendrocytes

J. Honnorat, B. Zalc, M. Belin, 1998, Journal of neuropathology and experimental neurology.

[Management of malignant gliomas diagnosed during pregnancy].

F. Ducray, J. Honnorat, P. Trouillas, 2006, Revue neurologique.

Paraneoplastic Peripheral Neuropathy Associated With Anti‐hu Antibodies. A Clinical And Electrophysiological Study Of 20 Patients

P. Convers, D. Michel, J. Honnorat, 2002 .

Paraneoplastic neurological syndromes: a practical approach to diagnosis and management

J. Honnorat, S. Irani, S. Binks, 2021, Practical Neurology.

Paraneoplastic subacute lower motor neuron syndrome associated with solid cancer

J. Honnorat, J. Pouget, S. Attarian, 2015, Journal of the Neurological Sciences.

Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy

J. Honnorat, J. Antoine, J. Camdessanché, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies

J. Honnorat, E. Decullier, D. Ricard, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors.

P. De Camilli, D. Michel, J. Honnorat, 1999, Archives of neurology.

Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis

F. Ducray, J. Honnorat, J. Delattre, 2015, Journal of Neurology.

Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies

J. Honnorat, N. Fabien, A. Vogrig, 2020, The Cerebellum.

Ipsilateral ptosis as main feature of tuberothalamic artery infarction

J. Honnorat, P. Trouillas, N. Nighoghossian, 2009, Neurological Sciences.

Gyriform infiltration as imaging biomarker for molecular glioblastomas

F. Ducray, J. Honnorat, D. Poncet, 2022, Journal of Neuro-Oncology.

Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.

J. Honnorat, M. Varrin-doyer, C. Confavreux, 2010, Brain : a journal of neurology.

Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer

F. Ducray, J. Honnorat, J. Delattre, 2013, Neurology.

[New concepts in limbic encephalitis].

J. Honnorat, 2009, Revue neurologique.

Anti-Hu-associated brainstem encephalitis

J. Honnorat, B. Giometto, A. Saiz, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Devic’s syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies

F. Ducray, J. Honnorat, E. Roullet, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

A new anti-neuronal antibody in a case of paraneoplastic limbic encephalitis associated with breast cancer

H. Urbach, J. Honnorat, R. Biniek, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: Data from the French-Italian HHT network

J. Honnorat, J. Saurin, E. Buscarini, 2007, Genetics in Medicine.

Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis.

L. Meijer, J. Honnorat, N. Loaëc, 2014, Neuro-oncology.

Contactin‐associated protein‐like 2, a protein of the neurexin family involved in several human diseases

J. Honnorat, O. Pascual, N. Noraz, 2018, The European journal of neuroscience.

Neuronal central nervous system syndromes probably mediated by autoantibodies

J. Honnorat, C. Hampe, V. Desestret, 2016, The European journal of neuroscience.

Guidelines for treatment of immune-mediated cerebellar ataxias

H. Mitoma, J. Honnorat, M. Hadjivassiliou, 2015, Cerebellum & Ataxias.

Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?

S. Vukusic, J. Honnorat, C. Confavreux, 2010, Archives of neurology.

Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis

J. Honnorat, C. Bien, M. Rosenfeld, 2020, Neurology.

Successful Management of Anti‐mGluR1 Encephalitis with Immunosuppressive Treatment: Dengue Virus as a Trigger?

J. Honnorat, A. Lannuzel, H. Chaumont, 2019, Movement disorders clinical practice.

Reversible myoclonus‐ataxia encephalitis related to anti‐mGLUR1 autoantibodies

O. Rascol, J. Honnorat, C. Brefel Courbon, 2019, Movement disorders : official journal of the Movement Disorder Society.

Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias

H. Mitoma, S. Kakei, J. Honnorat, 2015, The Cerebellum.

Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience

F. Ducray, J. Honnorat, B. Giometto, 2014, European journal of neurology.

[Clinical presentation of immune mediated cerebellar ataxia].

J. Honnorat, P. Trouillas, 2003, Revue neurologique.

A clinical approach to diagnosis of autoimmune encephalitis

A. Venkatesan, J. Honnorat, K. Rostásy, 2016, The Lancet Neurology.

Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia

J. Honnorat, M. Manto, C. Hampe, 2011, Orphanet journal of rare diseases.

Effects of anti–glutamic acid decarboxylase antibodies associated with neurological diseases

J. Honnorat, M. Pandolfo, M. Manto, 2007, Annals of neurology.

EFFECTS OF ANTI-GAD ANTIBODIES ASSOCIATED WITH NEUROLOGICAL DISEASES

J. Honnorat, M. Pandolfo, M. Manto, 2007 .

Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements.

J. Honnorat, P. Trouillas, C. Thivolet, 1995, Archives of neurology.

Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2

P. Fuhr, J. Honnorat, F. Zipp, 2021, Annals of neurology.

Cerebellar long-term depression and auto-immune target of auto-antibodies: the concept of LTDpathies

H. Mitoma, J. Honnorat, M. Manto, 2021, Molecular Biomedicine.

Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias

H. Mitoma, J. Honnorat, M. Manto, 2020, International journal of molecular sciences.

Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses

J. Honnorat, A. Vogrig, B. Joubert, 2022, The Cerebellum.

Screening for Tumours in Paraneoplastic Syndromes

J. Honnorat, R. Soffietti, N. Gilhus, 2011 .

Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force

J. Honnorat, R. Soffietti, N. Gilhus, 2011, European journal of neurology.

Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes

J. Honnorat, 2006, Acta neurologica Scandinavica. Supplementum.

Pregnancy outcomes in anti-NMDA receptor encephalitis

J. Honnorat, F. Leypoldt, E. Martinez-Hernandez, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Paraneoplastic opsomyoclonus, cerebellar ataxia and encephalopathy associated with anti-Purkinje cell antibodies

J. Honnorat, M. Trillet, J. Dalmau, 1997, Journal of Neurology.

Pp IX Silica Nanoparticles Demonstrate Differential Interactions with In Vitro Tumor Cell Lines and In Vivo Mouse Models of Human Cancers

L. Lévy, J. Honnorat, A. Duval, 2010, Photochemistry and photobiology.

Understanding auto-immune encephalitis in the ICU

A. Venkatesan, J. Honnorat, R. Sonneville, 2019, Intensive Care Medicine.

GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies

J. Honnorat, M. Manto, C. Hampe, 2018, Orphanet Journal of Rare Diseases.

Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis

J. Honnorat, C. Faivre-Sarrailh, D. Karagogeos, 2015, Front. Cell. Neurosci..

Matrix-Binding Vascular Endothelial Growth Factor (VEGF) Isoforms Guide Granule Cell Migration in the Cerebellum via VEGF Receptor Flk1

Paul Antoine Salin, R. D'Hooge, P. Carmeliet, 2010, The Journal of Neuroscience.

An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

Jean-Yves Delattre, Jérôme Honnorat, François Ducray, 2010, Molecular Cancer.

Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults

F. Ducray, M. Gabut, J. Honnorat, 2021, Neuro-oncology advances.

Comparative assessment of 5 methods (methylation‐specific polymerase chain reaction, methylight, pyrosequencing, methylation‐sensitive high‐resolution melting, and immunohistochemistry) to analyze O6‐methylguanine‐DNA‐methyltranferase in a series of 100 glioblastoma patients

M. Sanson, J. Honnorat, O. Chinot, 2012, Cancer.

Correction: SNP Array Analysis Reveals Novel Genomic Abnormalities Including Copy Neutral Loss of Heterozygosity in Anaplastic Oligodendrogliomas

F. Ducray, J. Honnorat, O. Chinot, 2013, PLoS ONE.

Methionine tumor starvation by erythrocyte‐encapsulated methionine gamma‐lyase activity controlled with per os vitamin B6

D. Maucort-Boulch, J. Honnorat, Vanessa Bourgeaux, 2017, Cancer medicine.

[Adult intramedullary gliomas].

J. Honnorat, O. Chinot, C. Lacroix, 2017, Neuro-Chirurgie.

Conventional MRI radiomics in patients with suspected early- or pseudo-progression

F. Ducray, J. Honnorat, M. Hermier, 2019, Neuro-oncology advances.

Regulation of Spine Development by Semaphorin3A through Cyclin-Dependent Kinase 5 Phosphorylation of Collapsin Response Mediator Protein 1

J. Honnorat, Y. Goshima, H. Usui, 2007, The Journal of Neuroscience.

Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo–Associated Paraneoplastic Cerebellar Degeneration

J. Honnorat, A. Viari, I. Treilleux, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Characteristics of cerebellar glioblastomas in adults

F. Ducray, J. Honnorat, D. Frappaz, 2018, Journal of Neuro-Oncology.

SNP Array Analysis Reveals Novel Genomic Abnormalities Including Copy Neutral Loss of Heterozygosity in Anaplastic Oligodendrogliomas

F. Ducray, J. Honnorat, O. Chinot, 2012, PloS one.

Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease

K. Mikoshiba, J. Honnorat, Y. Goshima, 2005, Genes to cells : devoted to molecular & cellular mechanisms.

Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.

F. Georges, J. Honnorat, L. Groc, 2012, Brain : a journal of neurology.

An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas

F. Ducray, Y. Marie, M. Sanson, 2014, BioMed research international.

Autoimmunity in paraneoplastic neurological disorders 1 This meeting was held at Somerville College, Oxford, April 6-7, 1997. 1

J. Honnorat, B. Giometto, A. Vincent, 1998, Journal of Neuroimmunology.

Transcriptional regulation of CRMP5 controls neurite outgrowth through Sox5

J. Honnorat, N. Chounlamountri, R. Besançon, 2017, Cellular and Molecular Life Sciences.

Aquaporin-4 antibody–negative neuromyelitis optica

J. Honnorat, C. Confavreux, R. Bernard-Valnet, 2013, Neurology.

Clinical genetics of familial progressive supranuclear palsy.

A. Lees, J. Honnorat, P. Pramstaller, 1999, Brain : a journal of neurology.

Old Microbleeds Are a Potential Risk Factor for Cerebral Bleeding After Ischemic Stroke: A Gradient-Echo T2*-Weighted Brain MRI Study

J C Froment, P Trouillas, L Derex, 2002, Stroke.

Immunoglobulin G antibodies to the N‐Methyl‐D‐aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses

J. Honnorat, F. Leypoldt, M. Reindl, 2015, Annals of neurology.

Collapsin response‐mediator protein 5 (CRMP5) phosphorylation at threonine 516 regulates neurite outgrowth inhibition

J. Honnorat, R. Besançon, C. Auger, 2014, The European journal of neuroscience.

Anti-CV2 autoantibodies and paraneoplastic neurological syndromes

J. Honnorat, V. Rogemond, 2000, Clinical reviews in allergy & immunology.

Glial Fibrillary Acidic Protein Autoimmunity

L. Kremer, J. Honnorat, F. Sellal, 2021, Neurology.

Glial Fibrillary Acidic Protein Autoimmunity A French Cohort Study

L. Kremer, J. Honnorat, F. Sellal, 2022 .

The pattern and diagnostic criteria of sensory neuronopathy: a case–control study

J. Honnorat, J. Antoine, P. Petiot, 2009, Brain : a journal of neurology.

CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.

F. Ducray, J. Honnorat, R. Khanna, 2015, Cancer research.

Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis

F. Ducray, J. Honnorat, J. Delattre, 2014, Neurology.

Pulmonary embolism: An unusual complication of cerebral venous thrombosis

J. Honnorat, P. Trouillas, N. Nighoghossian, 2005, Neurology.

French Intensive Care Society, International congress – Réanimation 2016

Paul P. Tallon, Stéphane Huot, B. Souweine, 2016, Annals of Intensive Care.

Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.

F. Ducray, J. Honnorat, O. Chinot, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differential Effects of PI3K and Dual PI3K/mTOR Inhibition in Rat Prolactin-Secreting Pituitary Tumors

J. Honnorat, K. Lucia, M. Theodoropoulou, 2016, Molecular Cancer Therapeutics.

The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study

J. Honnorat, H. Kretzschmar, T. Arzberger, 2015, Journal of Neural Transmission.

Childhood encephalitis in the Greater Mekong region (the SouthEast Asia Encephalitis Project): a multicentre prospective study

K. Bleakley, P. Newton, P. Debré, 2022, The Lancet. Global health.

Intellectual disability: dendritic anomalies and emerging genetic perspectives

J. Honnorat, R. Khanna, A. Duchemin, 2020, Acta Neuropathologica.

Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy.

A. Vighetto, B. Laurent, D. Michel, 1997, Archives of neurology.

Full recovery of agrypnia associated with anti-Lgi1 antibodies encephalitis under immunomodulatory treatment: a case report with sequential polysomnographic assessment.

F. Mauguière, S. Rheims, J. Honnorat, 2012, Sleep medicine.

Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities.

R. Redon, J. Honnorat, A. Toutain, 2021, American journal of human genetics.

ATAD3B is a human embryonic stem cell specific mitochondrial protein, re-expressed in cancer cells, that functions as dominant negative for the ubiquitous ATAD3A.

J. Honnorat, J. Baudier, A. Bennaceur-Griscelli, 2012, Mitochondrion.

Anti‐N‐Methyl‐d‐Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care

S. Demeret, J. Honnorat, J. Timsit, 2017, American journal of respiratory and critical care medicine.

Phosphorylation of Collapsin Response Mediator Protein 2 on Tyr-479 Regulates CXCL12-induced T Lymphocyte Migration*

J. Honnorat, M. Varrin-doyer, N. Noraz, 2009, Journal of Biological Chemistry.

Collapsin response mediator proteins (CRMPs)

J. Honnorat, S. Reibel, V. Rogemond, 2003, Molecular Neurobiology.

Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes

J. Honnorat, D. Aunis, M. Mattei, 1999, The European journal of neuroscience.

Intrathecal treatment of anti‐N‐Methyl‐d‐aspartate receptor encephalitis in children

J. Honnorat, M. Tardieu, K. Deiva, 2015, Developmental medicine and child neurology.

Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies

F. Ducray, J. Honnorat, J. Delattre, 2018, Journal of Neurology.

Neuroleptic intolerance in patients with anti-NMDAR encephalitis

M. Leboyer, F. Ducray, J. Honnorat, 2016, Neurology: Neuroimmunology & Neuroinflammation.

D-aspartate schizophrénie

M. Leboyer, J. Dausset, J. Honnorat, 2015 .

Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in children

J. Honnorat, N. Boddaert, O. Dulac, 2013, Clinical Neurophysiology.

Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004.

H. Duffau, L. Capelle, J. Honnorat, 2010, Neuro-oncology.

Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma

J. Honnorat, D. Poncet, R. Bolbos, 2015, Molecular Cancer.

Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis

K. Elliott, E. Mignot, J. Honnorat, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Telomere Profiling: Toward Glioblastoma Personalized Medicine

Tania L. Slatter, M. Beuve, J. Honnorat, 2013, Molecular Neurobiology.

Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study

F. Ducray, J. Honnorat, C. Julier, 2021, Journal of Neurology.

Multiplex family with GAD65-Abs neurologic syndromes

E. Mignot, J. Honnorat, N. Fabien, 2017, Neurology: Neuroimmunology & Neuroinflammation.

The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma.

F. Ducray, J. Honnorat, X. Armoiry, 2016, Neuro-oncology.

Radiotherapy for glioblastoma in the elderly.

Luc Taillandier, Pierre-Yves Bondiau, Jean-Yves Delattre, 2007, The New England journal of medicine.

Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France

J. Honnorat, A. Alentorn, M. Rabilloud, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Facial pain as first manifestation of anti-Hu paraneoplastic syndrome

F. Mauguière, P. Ryvlin, J. Honnorat, 2010, The Journal of Headache and Pain.

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

J. Blay, F. Ducray, S. Lantuejoul, 2021, Medical Oncology.

Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma

K. Hoang-Xuan, L. Capelle, F. Ducray, 2020, Clinical Neurology and Neurosurgery.

Initial chemotherapy in gliomatosis cerebri

K. Hoang-Xuan, H. Duffau, M. Sanson, 2004, Neurology.

ANOCEF group. Initial chemotherapy in gliomatosis cerebri

H. Duffau, M. Sanson, S. Taillibert, 2004 .

Autoimmune channelopathies in paraneoplastic neurological syndromes.

J. Honnorat, B. Joubert, 2015, Biochimica et biophysica acta.

Redifferentiation Therapy in Brain Tumors: Long-lasting Complete Regression of Glioblastomas and an Anaplastic Astrocytoma Under Long Term 1-alpha-hydroxycholecalciferol

J. Honnorat, A. Jouvet, P. Trouillas, 2004, Journal of Neuro-Oncology.

Nivolumab-induced myositis: A case report and a literature review

J. Honnorat, N. Fabien, B. Joubert, 2018, Journal of the Neurological Sciences.

Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status

François Cotton, Jacques Guyotat, Jérôme Honnorat, 2015, Journal of Neuro-Oncology.

Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma

F. Ferracci, J. Honnorat, R. Modzelewski, 2021, Frontiers in Cell and Developmental Biology.

Analysis of temozolomide resistance in low-grade gliomas by using a mechanistic mathematical model Running title : Resistance to temozolomide in low-grade gliomas

A. Samson, E. Ollier, F. Ducray, 2016 .

J. Honnorat, B. Giometto, J. Antoine, 2011, Journal of Neurology.

Isolation and Expression Pattern of Human Unc-33-Like Phosphoprotein 6/Collapsin Response Mediator Protein 5 (Ulip6/CRMP5): Coexistence with Ulip2/CRMP2 in Sema3A- Sensitive Oligodendrocytes

J. Honnorat, D. Ricard, M. Belin, 2001, The Journal of Neuroscience.

Slow evolution of cerebellar degeneration and chorea in a man with anti‐Yo antibodies

A. Vighetto, J. Honnorat, P. Krolak-Salmon, 2006, European journal of neurology.

Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review

J. Honnorat, A. Alentorn, N. Fabien, 2022, Journal of Neurology.

Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia—Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias

H. Mitoma, J. Honnorat, M. Manto, 2020, The Cerebellum.

Antibodies to CRMP3–4 associated with limbic encephalitis and thymoma

J. Honnorat, C. Vedeler, L. Oltedal, 2007, Clinical and experimental immunology.

High and Low Grade Oligodendrogliomas (ODG): Correlation of Amino-Acid and Glucose Uptakes Using PET and Histological Classifications

L. Cinotti, D. Le Bars, J. Honnorat, 2004, Journal of Neuro-Oncology.

Alterations of cerebral microcirculation in peritumoral edema: feasibility of in vivo sidestream dark-field imaging in intracranial meningiomas

F. Ducray, J. Honnorat, F. Cotton, 2020, Neuro-oncology advances.

Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation.

J. Honnorat, D. Meyronet, C. Auger, 2013, Experimental cell research.

Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis

J. Honnorat, M. Formaglio, V. Desestret, 2021, Journal of Neurology.

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial

Thomas C. Chen, R. Stupp, M. Taphoorn, 2018, JAMA oncology.

Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)

J. Honnorat, D. Frappaz, O. Chinot, 2018, The oncologist.

Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies

F. Ducray, J. Honnorat, J. Antoine, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies

M. Sanson, J. Honnorat, A. Alentorn, 2018, British Journal of Cancer.

Peri-ictal pseudoprogression in patients with brain tumor.

M. J. van den Bent, F. Ducray, M. Sanson, 2011, Neuro-oncology.

[Necrosis of a hypophyseal adenoma and ischemic cerebral vascular accident ].

J. Honnorat, P. Trouillas, N. Nighoghossian, 2002, Revue neurologique.

CTIM-25. A RANDOMIZED PHASE 3 STUDY OF NIVOLUMAB OR PLACEBO COMBINED WITH RADIOTHERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WITH METHYLATED MGMT PROMOTER: CHECKMATE 548

Jennie W. Taylor, M. Weller, J. Honnorat, 2021, Neuro-Oncology.

Current trends in the management of glioblastoma in a French University Hospital and associated direct costs

F. Ducray, J. Honnorat, D. Frappaz, 2016, Journal of clinical pharmacy and therapeutics.

Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis

J. Pariente, J. Honnorat, E. Uro-Coste, 2021, Brain communications.

CRMP5 Interacts with Tubulin to Inhibit Neurite Outgrowth, Thereby Modulating the Function of CRMP2

J. Honnorat, N. Chounlamountri, V. Perrot, 2010, The Journal of Neuroscience.

Increasing the Time Interval between PCV Chemotherapy Cycles as a Strategy to Improve Duration of Response in Low-Grade Gliomas: Results from a Model-Based Clinical Trial Simulation

Pauline Mazzocco, Jérôme Honnorat, François Ducray, 2015, Comput. Math. Methods Medicine.

Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders

M. Leboyer, J. Os, J. Honnorat, 2013, Front. Genet..

[Anti-neuronal antibodies and central nervous system diseases: contribution to diagnosis and pathophysiology].

J. Honnorat, J. Antoine, 2000, Revue neurologique.

Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes

J. Honnorat, B. Giometto, C. Vedeler, 2016, Journal of Neurology.

Beware of optic neuritis!

A. Vighetto, J. Honnorat, P. Krolak-Salmon, 2002, The Lancet Neurology.

Processing and Nuclear Localization of CRMP2 during Brain Development Induce Neurite Outgrowth Inhibition*

J. Honnorat, M. Belin, P. Giraudon, 2008, Journal of Biological Chemistry.

[JC virus infection and lympho-plasmocytic infiltration of the central nervous system revealed by a cerebellar syndrome].

J. Honnorat, P. Trouillas, N. Nighoghossian, 1999, Revue neurologique (Paris).

Simple partial status epilepticus and antiglycolipid IgM antibodies: possible epilepsy of autoimmune origin.

J. Honnorat, P. Moreau, B. Nogues, 1997, Archives of neurology.

Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4.

J. Honnorat, I. Treilleux, P. Mehlen, 2017, Oncotarget.

In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction

Adrien Didelot, Mario Manto, Jérôme Honnorat, 2010, Orphanet journal of rare diseases.

VEGF counteracts amyloid-β-induced synaptic dysfunction.

J. Honnorat, A. Buisson, N. Chounlamountri, 2021, Cell reports.

Involvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons

J. Honnorat, A. Duchemin, P. Kolattukudy, 2004, Molecular and Cellular Neuroscience.

Altered prepulse inhibition in mice with dendrite abnormalities of hippocampal neurons

J. Honnorat, A. Duchemin, P. Kolattukudy, 2008, Molecular Psychiatry.

Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.

Wei Li, P. Adeleine, J. Honnorat, 1998, Stroke.

Neuronal networks in mental diseases and neuropathic pain: Beyond brain derived neurotrophic factor and collapsin response mediator proteins.

J. Honnorat, R. Khanna, A. Duchemin, 2016, World journal of psychiatry.

Phosphorylation of CRMP2 (Collapsin Response Mediator Protein 2) Is Involved in Proper Dendritic Field Organization

K. Mikoshiba, J. Honnorat, Y. Goshima, 2012, The Journal of Neuroscience.

A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior

H. Luhmann, J. Honnorat, G. Malleret, 2016, Molecular Psychiatry.

Expanding Spectrum of Encephalitis With NMDA Receptor Antibodies in Young Children

J. Honnorat, M. Tardieu, A. Lebas, 2010, Journal of child neurology.

Surface dynamics of GluN2B‐NMDA receptors controls plasticity of maturing glutamate synapses

Jérôme Honnorat, Laurent Groc, Julien P Dupuis, 2014, The EMBO journal.

Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis

D. Rujescu, M. Leboyer, R. Kahn, 2020, Biological Psychiatry.

Recurrent cerebral venous thrombosis revealing paraneoplastic angiitis in Hodgkin’s lymphoma

G. Salles, F. Berger, J. Honnorat, 2008, Journal of Neuro-Oncology.

Factors Influencing Early Admission in a French Stroke Unit

P. Adeleine, J. Honnorat, P. Trouillas, 2002, Stroke.

Evidence of time‐dependent prognostic factors predicting early death but not long‐term outcome in primary CNS lymphoma: a study of 91 patients

J. Blay, Y. Drouet, J. Honnorat, 2013, Hematological oncology.

strategies to treat epilepsy, mood disorders, or even neurodegenerative diseases, such as Alzheimer's disease.

J. Honnorat, 2010 .

Value of Onconeural Antibodies in Checkpoint Inhibitor‐Related Toxicities

J. Honnorat, A. Vogrig, S. Muñiz-Castrillo, 2020, Annals of neurology.

[Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2/CRMP5 antibodies and two different tumors].

J. Honnorat, T. Ritzenthaler, J. Verret, 2010, Revue neurologique.

Mononeuropathie multiple et anticorps anti-Ma2

J. Honnorat, D. Figarella-Branger, P. Labauge, 2008 .

[Ma2 antibody and multiple mononeuropathies].

J. Honnorat, D. Figarella-Branger, P. Labauge, 2008, Revue neurologique.

NMO-IgG and Devic's neuromyelitis optica: a French experience

P. Vermersch, S. Vukusic, J. Honnorat, 2008, Multiple sclerosis.

[Cortical thrombophlebitis and developmental venous anomalies].

J. Honnorat, P. Trouillas, N. Nighoghossian, 1999, Revue neurologique.

Intravenous tPA in acute ischemic stroke related to internal carotid artery dissection

J. Honnorat, P. Trouillas, N. Nighoghossian, 2000, Neurology.

Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis

E. Mignot, J. Honnorat, A. Alentorn, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies

F. Ducray, S. Rheims, J. Honnorat, 2020, Journal of Neurology.

Differential Expression of Collapsin Response Mediator Proteins (CRMP/ULIP) in Subsets of Oligodendrocytes in the Postnatal Rodent Brain

J. Honnorat, D. Ricard, N. Spassky, 2000, Molecular and Cellular Neuroscience.

TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration

J. Honnorat, S. Gupton, Y. Couté, 2018, The Cerebellum.

J. Honnorat, P. Barthélémy, C. Tranchant, 2021, Journal of Neuroimmune Pharmacology.

Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions

H. Mitoma, Y. Yanagawa, J. Delgado-García, 2015, Front. Behav. Neurosci..

Quantification of Iron-Labeled Cells with Positive Contrast in Mouse Brains

J. Honnorat, N. Nighoghossian, S. Nataf, 2011, Molecular Imaging and Biology.

MRI Monitoring of Neuroinflammation in Mouse Focal Ischemia

Olivier Beuf, Jean-Baptiste Pialat, Jérôme Honnorat, 2007, Stroke.

VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation

Paul Antoine Salin, P. Carmeliet, D. Schmucker, 2011, Proceedings of the National Academy of Sciences.

Potential Role of Anti‐GAD Antibodies in Abnormal Eye Movements

A. Vighetto, C. Tilikete, J. Honnorat, 2005, Annals of the New York Academy of Sciences.

Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors

J. Guyotat, J. Honnorat, F. Cotton, 2006, Neuroradiology.

[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study].

B. Chauffert, S. Taillibert, J. Honnorat, 2008, Revue neurologique.

French brain tumor data bank: Methodology and first results on 10,000 cases

L. Capelle, J. Honnorat, D. Frappaz, 2007, Journal of Neuro-Oncology.

Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats

J. Honnorat, F. Foti, M. Manto, 2013, Orphanet Journal of Rare Diseases.

Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis

F. Ducray, J. Honnorat, D. Ricard, 2011, Journal of Neurology.

Mapping CRMP3 domains involved in dendrite morphogenesis and voltage-gated calcium channel regulation

J. Honnorat, M. Khanna, Sarah M. Wilson, 2013, Journal of Cell Science.

Baseline Magnetic Resonance Imaging Parameters and Stroke Outcome in Patients Treated by Intravenous Tissue Plasminogen Activator

P. Adeleine, J. Honnorat, P. Trouillas, 2003, Stroke.

Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas

J. Honnorat, F. Cotton, J. Guyotat, 2010, Journal of Neuro-Oncology.

Calpain product of WT‐CRMP2 reduces the amount of surface NR2B NMDA receptor subunit

C. Gauchy, J. Glowinski, J. Honnorat, 2006, Journal of neurochemistry.

Unclear association between COVID-19 and Guillain-Barré syndrome

G. Gigli, J. Honnorat, J. Antoine, 2021, Brain : a journal of neurology.

Altered expression of CRMPs in the brain of bovine spongiform encephalopathy-infected mice during disease progression

J. Honnorat, P. Giraudon, S. Reibel, 2009, Brain Research.

Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain

C. Gauchy, J. Glowinski, J. Honnorat, 2005, The Journal of comparative neurology.

Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator

P. Adeleine, J. Honnorat, P. Trouillas, 2004, Journal of the Neurological Sciences.

Opsoclonus, limbic encephalitis, anti‐Ma2 antibodies and gastric adenocarcinoma

A. Vighetto, C. Tilikete, J. Honnorat, 2012, European journal of neurology.

The Clinical Concept of LTDpathy: Is Dysregulated LTD Responsible for Prodromal Cerebellar Symptoms?

H. Mitoma, J. Honnorat, M. Manto, 2022, Brain sciences.

NEUROSARCOIDOSIS WITH DIENCEPHALITIS AND ANTI-Ma2 ANTIBODIES

J. Honnorat, A. Jouvet, V. Desestret, 2010, Neurology.

Autoimmune limbic encephalitis: an expanding concept

J. Honnorat, 2010, The Lancet Neurology.

Delayed onset of a second paraneoplastic neurological syndrome in eight patients

F. Ducray, J. Honnorat, J. Antoine, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features

M. Elsensohn, D. Maucort-Boulch, J. Honnorat, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis

A. Cebrian-Silla, J. García-Verdugo, J. Honnorat, 2017, Neurology.

Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome

F. Ducray, F. Mauguière, S. Vukusic, 2015, Neurology.

Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator

P. Adeleine, J. Honnorat, P. Trouillas, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Fatal Anti-Ma2 Encephalitis Related to Treatment of Malignant Pleural Mesothelioma With a Combination of Anti-Programmed Death 1 and Anti-Cytotoxic T-Lymphocyte Associated Protein 4 Antibodies.

J. Honnorat, F. Toulgoat, J. Raimbourg, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Recurrent seizures of autoimmune origin: emerging phenotypes

J. Honnorat, L. Tyvaert, A. Verger, 2021, Journal of Neurology.

GAD65-Ab encephalitis and subtle focal status epilepticus.

J. Honnorat, L. Tyvaert, A. Verger, 2019, Epileptic disorders : international epilepsy journal with videotape.

rtPA intravenous thrombolysis in anterior choroidal artery territory stroke

J. Honnorat, P. Trouillas, N. Nighoghossian, 2000, Neurology.

Pure monomelic sensory neuronopathy associated with anti‐yo antibodies

J. Honnorat, P. Labauge, G. Castelnovo, 2012, Muscle & nerve.

Distinct movement disorders in contactin-associated-protein-like-2 antibody associated autoimmune encephalitis.

G. Deuschl, J. Honnorat, C. Geis, 2022, Brain : a journal of neurology.

Dramatic improvement after rituximab in a patient with paraneoplastic treatment‐refractory Morvan syndrome associated with anti‐CASPR2 antibodies

F. Ducray, J. Honnorat, P. Petiot, 2013, European journal of neurology.

Transient alterations in granule cell proliferation, apoptosis and migration in postnatal developing cerebellum of CRMP1−/– mice

Paul Antoine Salin, J. Honnorat, Y. Goshima, 2006, Genes to cells : devoted to molecular & cellular mechanisms.

Collapsin response mediator protein-3/unc-33-like protein-4 gene: organization, chromosomal mapping and expression in the developing mouse brain.

N. Copeland, D. Gilbert, N. Jenkins, 2000, Gene.

Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients

M. Leboyer, R. Yolken, H. Gréa, 2017, Nature Communications.

Olaparib in recurrent IDH-mutant high-grade glioma (OLAGLI).

D. Maucort-Boulch, F. Ducray, M. Sanson, 2021 .

A New Mutation of the τ Gene, G303V, in Early-Onset Familial Progressive Supranuclear Palsy

J. Hoenicka, J. Honnorat, S. Thobois, 2005 .

Glioblastoma as differential diagnosis of autoimmune encephalitis

F. Ducray, O. Martinaud, J. Honnorat, 2018, Journal of Neurology.

[Long-term outcome in patients with symptomatic low-grade oligodendrogliomatous tumors treated by cytotoxic agents].

J. Honnorat, P. Trouillas, N. Nighoghossian, 2006, Revue neurologique (Paris).

Hyperthyroidism and Cerebral Venous Thrombosis

J. Honnorat, P. Trouillas, N. Nighoghossian, 2005, European Neurology.

Expression of collapsin response mediator proteins 1, 2 and 5 is differentially regulated in newly generated and mature neurons of the adult olfactory system

J. Honnorat, F. Jourdan, A. Veyrac, 2005, The European journal of neuroscience.

Collapsin Response Mediator Protein 1 Mediates Reelin Signaling in Cortical Neuronal Migration

K. Mikoshiba, J. Honnorat, Y. Goshima, 2006, The Journal of Neuroscience.

Cell-and single molecule-based methods to detect anti-NMDA receptor autoantibodies in first episode psychosis patients from the OPTiMiSE project

M. Leboyer, R. Kahn, P. McGuire, 2017 .

Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies

J. Honnorat, M. Manto, J. Dalmau, 2011, Journal of Neurology.

Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics

M. Leboyer, H. Gréa, J. Honnorat, 2019, Front. Psychiatry.

OBSERVATION A New Mutation of the Gene , G 303 V , in Early-Onset Familial Progressive Supranuclear Palsy

J. Hoenicka, J. Honnorat, S. Thobois, 2022 .

Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies

S. Rheims, J. Honnorat, N. Shor, 2022, Journal of Neurology.

Anti-aquaporin-4 antibodies in Devic’s neuromyelitis optica: therapeutic implications

Christian Confavreux, Jérôme Honnorat, Sandra Vukusic, 2010, Therapeutic advances in neurological disorders.

Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes

J. Honnorat, N. Fabien, V. Desestret, 2020, Neurology: Neuroimmunology & Neuroinflammation.

New Findings in Adult Opsoclonus-Myoclonus Syndrome.

J. Honnorat, 2016, JAMA neurology.

Cerebellar vermis hypermetabolism in opsoclonus myoclonus without onconeural antibodies

J. Honnorat, F. Pico, I. Taifas, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Clinical/Scientific Notes

J. Honnorat, F. Pico, I. Taifas, 2015 .

Anti‐N‐methyl‐D‐aspartate receptor encephalitis with acute disseminated encephalomyelitis‐like MRI features

F. Ducray, J. Honnorat, R. Marignier, 2012, European journal of neurology.

[Which role of antineural autoantibodies in central nervous system diseases?].

J. Honnorat, 2008, Revue neurologique.

Opposing Morphogenetic Defects on Dendrites and Mossy Fibers of Dentate Granular Neurons in CRMP3-Deficient Mice

J. Honnorat, R. Khanna, A. Duchemin, 2018, Brain sciences.

Anti-GAD antibodies and periodic alternating nystagmus.

A. Vighetto, C. Tilikete, J. Honnorat, 2005, Archives of neurology.

Effect of CRMP3 expression on dystrophic dendrites of hippocampal neurons

J. Honnorat, R. Khanna, A. Duchemin, 2011, Molecular Psychiatry.

Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment

J. Honnorat, A. Vogrig, S. Muñiz-Castrillo, 2020, Journal of Neurology.

Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis

J. Honnorat, I. Treilleux, K. Mokhtari, 2019, Acta neuropathologica communications.

Multiplex family with GAD65-Abs neurologic syndromes

E. Mignot, J. Honnorat, N. Fabien, 2017, Neurology: Neuroimmunology & Neuroinflammation.

B. Chauffert, J. Honnorat, D. Frappaz, 2014 .

LTDpathies: a Novel Clinical Concept

H. Mitoma, J. Honnorat, M. Manto, 2021, The Cerebellum.

CRMP5 Regulates Generation and Survival of Newborn Neurons in Olfactory and Hippocampal Neurogenic Areas of the Adult Mouse Brain

J. Honnorat, F. Jourdan, A. Veyrac, 2011, PLoS ONE.

Molecular cloning of a new unc-33-like cDNA from rat brain and its relation to paraneoplastic neurological syndromes.

M. Baudry, J. Honnorat, Y. Rong, 1997, Brain research. Molecular brain research.

Is autoimmune limbic encephalitis a channelopathy?

J. Honnorat, 2010, The Lancet Neurology.

Hu-antibody-positive patients with or without cancer have similar clinical profiles

A. Twijnstra, J. Honnorat, Y. Blanco, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Mapping and kinetics of microglia/neuron cell‐to‐cell contacts in the 6‐OHDA murine model of Parkinson's disease

J. Honnorat, S. Nataf, F. Chrétien, 2013, Glia.

Syk kinase is phosphorylated in specific areas of the developing nervous system

J. Honnorat, N. Noraz, H. Boudin, 2011, Neuroscience Research.

Characteristics of gliomas in patients with somatic IDH mosaicism

F. Ducray, M. Sanson, J. Honnorat, 2016, Acta neuropathologica communications.

Contents Vol. 16, 2003

Cheryl C. H. Yang, A. Rahimi, I. König, 2003, Cerebrovascular Diseases.

[CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin].

J. Honnorat, F. Poitevin, C. Caudie, 2005, Annales de Biologie Clinique.

Autoimmune encephalopathies

J. Honnorat, J. Carter, 2013, Neurology.

Chemotherapy is the cornerstone of the combined surgical treatment of lung cancer with synchronous brain metastases.

N. Girard, J. Honnorat, V. Cottin, 2006, Lung cancer.

Post-herpetic anti-N-methyl-d-aspartate receptor encephalitis in a pregnant woman.

J. Honnorat, J. Cassereau, M. Tailland, 2019, Revue neurologique.

A mouse model of autoimmune encephalitis.

J. Honnorat, O. Pascual, V. Desestret, 2015, Brain : a journal of neurology.

The Syk kinases orchestrate cerebellar granule cell tangential migration

J. Honnorat, N. Noraz, N. Chounlamountri, 2017, Neuroscience.

Collateral-CA1 Synapses Mediates Metaplasticity mGlu1 Receptor-Induced LTD of NMDA Receptor Transmission Selectively at Schaffer

Z. Bashir, E. Hanse, J. Honnorat, 2015 .

Thrombolytic therapy in acute ischemic stroke patients with cardiac thrombus

J. Honnorat, P. Trouillas, N. Nighoghossian, 2001, Neurology.

CSF HIV RNA Escape in Opsoclonus-Myoclonus-Ataxia Syndrome: Case Report and Review of the Literature

J. Honnorat, M. Manto, P. Cabaraux, 2020, Frontiers in Neurology.

Mild Encephalitis/Encephalopathy with reversible splenial lesion syndrome: An unusual presentation of anti-GFAP astrocytopathy.

C. Adamsbaum, J. Honnorat, H. Maurey, 2020, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Paraneoplastic neurological syndromes

J. Honnorat, J. Antoine, 2007, Orphanet journal of rare diseases.

Cyclophosphamide-responsive Lgi1-related limbic encephalitis with basal ganglia hypermetabolism

J. Honnorat, E. Thouvenot, D. Renard, 2016, Acta Neurologica Belgica.

Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes.

J. Honnorat, A. Jouvet, M. Fèvre-Montange, 2008, Clinical neuropathology.

Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease

B. Gaymard, J. Honnorat, I. Arnulf, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Hyperacute Diffusion-Weighted MRI in Basilar Occlusion Treated with Intra-Arterial t-PA

J. Honnorat, P. Trouillas, N. Nighoghossian, 1999, Cerebrovascular Diseases.

Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis

J. Honnorat, I. Treilleux, K. Mokhtari, 2019, Acta Neuropathologica Communications.